NFKB1 and psoriasis: Though NF-κB is a powerful activation regulator of NLRP3, the contribution of NLRP3 inflammasome to imiquimod-induced psoriasis remains controversial considering the broad ant-inflammatory activity of BAY 11-7082 (Juliana et al., 2010).